Concepedia

Publication | Closed Access

Natalizumab in progressive MS

DOI

126

Citations

35

References

2014

Year

Jeppe Romme Christensen, Rikke Ratzer, Lars Börnsen, Mark Lyksborg, Ellen Garde, Tim B. Dyrby, Hartwig R. Siebner, Per Soelberg Sørensen, Finn Sellebjerg
Neurology

Abstract

This study provides Class IV evidence that in patients with progressive MS, natalizumab reduces biomarkers of intrathecal inflammation.

References

YearCitations

Page 1